基础设施类:公司以信托资金贷款、股权投资等方式, 运用于城市基础设施建设以及政府重大工程建设(如城市集中供水、供热、供气以及高等级公路等项目), 为基础设施建设搭建融资平台, 为受益人获取稳健的投资收益。英语翻译

Infrastructure categories: the Company builds financing platform for infrastructure construction and obtain stable investment profit for the beneficiary through trust fund loans, equity investments, etc., used in the construction of urban infrastructure and major government projects (such as the projects of urban central water supply, heat supply, gas supply and highway, etc).

房地产类:公司利用贷款、投资、收益权转让、融资租赁等各种金融工具为房地产企业提供资金支持与金融服务, 并特别关注拥有收益型物业的房地产企业, 积极探索房地产产业基金和房地产投资信托(REITS)。为委托人提供投资房地产的专业理财途径, 分享房地产行业利润。

Real estate categories: the company provides financial support and financial services for the real estate enterprises using financial instruments including loans, investments, usufruct assignment, finance leasing and etc.. The Company pays particular attention to real estate enterprises possessing income-property, and actively explores into real estate industry fund and real estate investment trusts (REITS). The Company provides professional financing ways of real estate to the client to share the profits of real estate industry.

矿业类: 公司依托内蒙古独特的矿产资源优势, 以信托资金股权投资为主, 贷款为辅; 以矿业行业整合和大宗并购为主, 参与探矿、采矿各阶段矿业投资为辅; 既为信托资金委托人提供矿业投资机会、获取投资收益, 又为优质矿业企业提供投、融资安排。日语翻译

Mining categories: The company relies on unique mineral resources advantage of Inner Mongolia, mainly engages in trust fund and equity investments with loans supplemented secondarily; mainly engages in consolidation and mergers and acquisitions of large mining industry with the participation in various stages of mining investment including prospecting, and mining, supplemented secondarily; the Company provides the clients of trust fund with opportunities of mining investment to access to investment income, but also makes investment and financing arrangements for high-quality mining enterprises.

医药类: 利用自有专业化团队, 致力于拥有自主知识产权且具备新品种研发能力的药企, 采用多种形式的股权投资, 通过建立退出渠道并设计退出方案, 极大的降低投资风险, 为投资人实现投资回报利益最大化。

Pharmaceutical categories: Using its own professional team, the Company is committing to possessing pharmaceutical companies with their own intellectual property right and the ability to develop new varieties, using various forms of equity investment, through the establishment of withdrawal channels and design of withdrawal program, which greatly reduces investment risk, and achieves the maximum benefits return for the investors.